{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T07:01:51Z","timestamp":1794294111322,"version":"4.9.0"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:00Z","timestamp":1791158400000},"content-version":"vor","delay-in-days":33,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL118114"],"award-info":[{"award-number":["R01HL118114"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R01GM102491"],"award-info":[{"award-number":["R01GM102491"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-77341-2","type":"journal-article","created":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T15:05:12Z","timestamp":1788361512000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Trifluoroacetate mediated reduction of atherosclerosis in mice"],"prefix":"10.1038","volume":"17","author":[{"given":"Wei","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey S.","family":"Black","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3438-3751","authenticated-orcid":false,"given":"Romana","family":"Moench","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katayoon","family":"Marzban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Antonio","family":"Raygoza Garay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-2698-1515","authenticated-orcid":false,"given":"James J.","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8448-5804","authenticated-orcid":false,"given":"Louis","family":"Conway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio F. M.","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8509-9289","authenticated-orcid":false,"given":"Christopher G.","family":"Parker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0427-563X","authenticated-orcid":false,"given":"Alan","family":"Saghatelian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1879-5900","authenticated-orcid":false,"given":"Luke J.","family":"Leman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5997-9271","authenticated-orcid":false,"given":"M. Reza","family":"Ghadiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,2]]},"reference":[{"key":"77341_CR1","doi-asserted-by":"publisher","first-page":"442","DOI":"10.3390\/ph13120442","volume":"13","author":"K Sikora","year":"2020","unstructured":"Sikora, K., Ja\u015bkiewicz, M., Neubauer, D., Migo\u0144, D. & Kamysz, W. The role of counter-ions in peptides\u2014an overview. Pharmaceuticals 13, 442 (2020).","journal-title":"Pharmaceuticals"},{"key":"77341_CR2","doi-asserted-by":"publisher","first-page":"2811","DOI":"10.1074\/jbc.M806409200","volume":"284","author":"C Liu","year":"2009","unstructured":"Liu, C. et al. Lactate inhibits lipolysis in fat cells through activation of an orphan G-protein-coupled receptor, GPR81. J. Biol. Chem. 284, 2811\u20132822 (2009).","journal-title":"J. Biol. Chem."},{"key":"77341_CR3","doi-asserted-by":"publisher","first-page":"10628","DOI":"10.1074\/jbc.M110.210872","volume":"286","author":"J Schmidt","year":"2011","unstructured":"Schmidt, J. et al. Selective orthosteric free fatty acid receptor 2 (FFA2) agonists: identification of the structural and chemical requirements for selective activation of FFA2 versus FFA3. J. Biol. Chem. 286, 10628\u201310640 (2011).","journal-title":"J. Biol. Chem."},{"key":"77341_CR4","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1006\/bbrc.2001.5291","volume":"285","author":"J Han","year":"2001","unstructured":"Han, J., Kim, N. & Kim, E. Trifluoroacetic acid activates ATP-sensitive K+ channels in rabbit ventricular myocytes. Biochem. Biophys. Res. Commun. 285, 1136\u20131142 (2001).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"77341_CR5","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.neuropharm.2012.04.011","volume":"63","author":"ME Tipps","year":"2012","unstructured":"Tipps, M. E., Iyer, S. V. & John Mihic, S. Trifluoroacetate is an allosteric modulator with selective actions at the glycine receptor. Neuropharmacology 63, 368\u2013373 (2012).","journal-title":"Neuropharmacology"},{"key":"77341_CR6","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1007\/s11030-022-10505-6","volume":"27","author":"C Ardino","year":"2023","unstructured":"Ardino, C. et al. The impact of counterions in biological activity: case study of antibacterial alkylguanidino ureas. Mol. Div. 27, 1489\u20131499 (2023).","journal-title":"Mol. Div."},{"key":"77341_CR7","first-page":"E779","volume":"277","author":"J Cornish","year":"1999","unstructured":"Cornish, J. et al. Trifluoroacetate, a contaminant in purified proteins, inhibits proliferation of osteoblasts and chondrocytes. Am. J. Physiol. 277, E779\u2013E783 (1999).","journal-title":"Am. J. Physiol."},{"key":"77341_CR8","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.mvr.2009.07.001","volume":"78","author":"B Bussolati","year":"2009","unstructured":"Bussolati, B., Ribatti, D., Munaron, L., Bartorelli, A. & Bussolati, G. Anti-angiogenic properties of calcium trifluoroacetate. Microvasc. Res. 78, 272\u2013277 (2009).","journal-title":"Microvasc. Res."},{"key":"77341_CR9","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1194\/jlr.M049262","volume":"55","author":"Y Zhao","year":"2014","unstructured":"Zhao, Y. et al. In vivo efficacy of HDL-like nanolipid particles containing multivalent peptide mimetics of apolipoprotein A-I. J. Lipid Res. 55, 2053\u20132063 (2014).","journal-title":"J. Lipid Res."},{"key":"77341_CR10","doi-asserted-by":"publisher","first-page":"13414","DOI":"10.1021\/ja404714a","volume":"135","author":"Y Zhao","year":"2013","unstructured":"Zhao, Y. et al. Mimicry of high-density lipoprotein: functional peptide-lipid nanoparticles based on multivalent peptide constructs. J. Am. Chem. Soc. 135, 13414\u201313424 (2013).","journal-title":"J. Am. Chem. Soc."},{"key":"77341_CR11","doi-asserted-by":"publisher","first-page":"19925","DOI":"10.1021\/acs.est.4c06189","volume":"58","author":"HPH Arp","year":"2024","unstructured":"Arp, H. P. H., Gredelj, A., Gl\u00fcge, J., Scheringer, M. & Cousins, I. T. The global threat from the irreversible accumulation of trifluoroacetic acid (TFA). Environ. Sci. Technol. 58, 19925\u201319935 (2024).","journal-title":"Environ. Sci. Technol."},{"key":"77341_CR12","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1007\/s00204-023-03454-y","volume":"97","author":"W Dekant","year":"2023","unstructured":"Dekant, W. & Dekant, R. Mammalian toxicity of trifluoroacetate and assessment of human health risks due to environmental exposures. Arch. Toxicol. 97, 1069\u20131077 (2023).","journal-title":"Arch. Toxicol."},{"key":"77341_CR13","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.watres.2017.09.045","volume":"126","author":"M Scheurer","year":"2017","unstructured":"Scheurer, M. et al. Small, mobile, persistent: Trifluoroacetate in the water cycle \u2013 overlooked sources, pathways, and consequences for drinking water supply. Water Res. 126, 460\u2013471 (2017).","journal-title":"Water Res."},{"key":"77341_CR14","doi-asserted-by":"publisher","first-page":"e2020GL087535","DOI":"10.1029\/2020GL087535","volume":"47","author":"HM Pickard","year":"2020","unstructured":"Pickard, H. M. et al. Ice core record of persistent short-chain fluorinated alkyl acids: evidence of the impact from global environmental regulations. Geophys. Res. Lett. 47, e2020GL087535 (2020).","journal-title":"Geophys. Res. Lett."},{"key":"77341_CR15","doi-asserted-by":"publisher","first-page":"100807","DOI":"10.1016\/j.cogsc.2023.100807","volume":"41","author":"F Freeling","year":"2023","unstructured":"Freeling, F. & Bj\u00f6rnsdotter, M. K. Assessing the environmental occurrence of the anthropogenic contaminant trifluoroacetic acid (TFA). Curr. Opin. Green. Sustain. Chem. 41, 100807 (2023).","journal-title":"Curr. Opin. Green. Sustain. Chem."},{"key":"77341_CR16","doi-asserted-by":"publisher","first-page":"105295","DOI":"10.1016\/j.envint.2019.105295","volume":"134","author":"Y Duan","year":"2020","unstructured":"Duan, Y., Sun, H., Yao, Y., Meng, Y. & Li, Y. Distribution of novel and legacy per-\/polyfluoroalkyl substances in serum and its associations with two glycemic biomarkers among chinese adult men and women with normal blood glucose levels. Environ. Int. 134, 105295 (2020).","journal-title":"Environ. Int."},{"key":"77341_CR17","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/clpt.2008.97","volume":"84","author":"E Kharasch","year":"2008","unstructured":"Kharasch, E. Adverse drug reactions with halogenated anesthetics. Clin. Pharmacol. Ther. 84, 158\u2013162 (2008).","journal-title":"Clin. Pharmacol. Ther."},{"key":"77341_CR18","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1016\/S0140-6736(96)91011-9","volume":"347","author":"ED Kharasch","year":"1996","unstructured":"Kharasch, E. D., Hankins, D., Mautz, D. & Thummel, K. E. Identification of the enzyme responsible for oxidative halothane metabolism: implications for prevention of halothane hepatitis. Lancet 347, 1367\u20131371 (1996).","journal-title":"Lancet"},{"key":"77341_CR19","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1097\/00000542-197401000-00015","volume":"40","author":"BenA Hitt","year":"1974","unstructured":"Hitt, B. enA. et al. Metabolism of isoflurane in Fischer 344 rats and man. Anesthesiology 40, 62\u201367 (1974).","journal-title":"Anesthesiology"},{"key":"77341_CR20","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1161\/01.RES.0000181229.69508.2f","volume":"97","author":"M Navab","year":"2005","unstructured":"Navab, M. et al. Oral small peptides render HDL antiinflammatory in mice and monkeys and reduce atherosclerosis in ApoE null mice. Circ. Res. 97, 524\u2013532 (2005).","journal-title":"Circ. Res."},{"key":"77341_CR21","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1002\/psc.793","volume":"13","author":"VV Andrushchenko","year":"2007","unstructured":"Andrushchenko, V. V., Vogel, H. J. & Prenner, E. J. Optimization of the hydrochloric acid concentration used for trifluoroacetate removal from synthetic peptides. J. Pept. Sci. 13, 37\u201343 (2007).","journal-title":"J. Pept. Sci."},{"key":"77341_CR22","doi-asserted-by":"publisher","first-page":"612089","DOI":"10.1155\/2010\/612089","volume":"2010","author":"M Rakhshandehroo","year":"2010","unstructured":"Rakhshandehroo, M., Knoch, B., M\u00fcller, M. & Kersten, S. Peroxisome proliferator-activated receptor alpha target genes. PPAR Res. 2010, 612089 (2010).","journal-title":"PPAR Res."},{"key":"77341_CR23","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.tox.2007.09.030","volume":"246","author":"FJ Gonzalez","year":"2008","unstructured":"Gonzalez, F. J. & Shah, Y. M. PPAR\u03b1: Mechanism of species differences and hepatocarcinogenesis of peroxisome proliferators. Toxicology 246, 2\u20138 (2008).","journal-title":"Toxicology"},{"key":"77341_CR24","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1161\/hq1101.098228","volume":"21","author":"SM Post","year":"2001","unstructured":"Post, S. M. et al. Fibrates suppress bile acid synthesis via peroxisome proliferator\u2013activated receptor-\u03b1\u2013mediated downregulation of cholesterol 7\u03b1-hydroxylase and sterol 27-hydroxylase expression. Arterioscler. Thromb. Vasc. Biol. 21, 1840\u20131845 (2001).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"77341_CR25","doi-asserted-by":"publisher","first-page":"28947","DOI":"10.1074\/jbc.M002782200","volume":"275","author":"MC Hunt","year":"2000","unstructured":"Hunt, M. C. et al. The peroxisome proliferator-activated receptor \u03b1 (PPAR\u03b1) regulates bile acid biosynthesis. J. Biol. Chem. 275, 28947\u201328953 (2000).","journal-title":"J. Biol. Chem."},{"key":"77341_CR26","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.2174\/1389201011208062435","volume":"13","author":"J Jawien","year":"2012","unstructured":"Jawien, J. The role of an experimental model of atherosclerosis: Apoe-knockout mice in developing new drugs against atherogenesis. Curr. Pharm. Biotechnol. 13, 2435\u20132439 (2012).","journal-title":"Curr. Pharm. Biotechnol."},{"key":"77341_CR27","doi-asserted-by":"publisher","first-page":"3223","DOI":"10.2337\/db10-0844","volume":"59","author":"C Morgantini","year":"2010","unstructured":"Morgantini, C. et al. Apolipoprotein A-I mimetic peptides prevent atherosclerosis development and reduce plaque inflammation in a murine model of diabetes. Diabetes 59, 3223\u20133228 (2010).","journal-title":"Diabetes"},{"key":"77341_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-88430-1","volume":"11","author":"P Dun\u00e9r","year":"2021","unstructured":"Dun\u00e9r, P. et al. Antibodies against apob100 peptide 210 inhibit atherosclerosis in Apoe-\/- mice. Sci. Rep. 11, 9022 (2021).","journal-title":"Sci. Rep."},{"key":"77341_CR29","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1515\/CCLM.2005.085","volume":"43","author":"K Wouters","year":"2005","unstructured":"Wouters, K., Shiri-Sverdlov, R., Gorp, P. J. V., Bilsen, M. V. & Hofker, M. H. Understanding hyperlipidemia and atherosclerosis: Lessons from genetically modified Apoe and Ldlr mice. Clin. Chem. Lab. Med. 43, 470\u2013479 (2005).","journal-title":"Clin. Chem. Lab. Med."},{"key":"77341_CR30","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1097\/01.fjc.0000162764.12309.25","volume":"46","author":"V DeClercq","year":"2005","unstructured":"DeClercq, V. et al. Paradoxical effects of fenofibrate and nicotinic acid in apo E-deficient mice. J. Cardiovasc. Pharmacol. 46, 18\u201324 (2005).","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"77341_CR31","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1042\/bj20030105","volume":"373","author":"T Fu","year":"2003","unstructured":"Fu, T., Kashireddy, P. & Borensztajn, J. The peroxisome-proliferator-activated receptor alpha agonist ciprofibrate severely aggravates hypercholesterolaemia and accelerates the development of atherosclerosis in mice lacking apolipoprotein E. Biochem. J. 373, 941\u2013947 (2003).","journal-title":"Biochem. J."},{"key":"77341_CR32","doi-asserted-by":"publisher","first-page":"48051","DOI":"10.1074\/jbc.M206966200","volume":"277","author":"H Duez","year":"2002","unstructured":"Duez, H. et al. Reduction of atherosclerosis by the peroxisome proliferator-activated receptor \u03b1 agonist fenofibrate in mice. J. Biol. Chem. 277, 48051\u201348057 (2002).","journal-title":"J. Biol. Chem."},{"key":"77341_CR33","doi-asserted-by":"publisher","first-page":"439","DOI":"10.2147\/DMSO.S234665","volume":"13","author":"R Bened\u00e9-Ubieto","year":"2020","unstructured":"Bened\u00e9-Ubieto, R., Est\u00e9vez-V\u00e1zquez, O., Ramadori, P., Cubero, F. J. & Nevzorova, Y. A. Guidelines and considerations for metabolic tolerance tests in mice. Diab Metab. Syndr. Obes. 13, 439\u2013450 (2020).","journal-title":"Diab Metab. Syndr. Obes."},{"key":"77341_CR34","doi-asserted-by":"crossref","unstructured":"Wang, C. Y. & Liao, J. K. in mTOR: Methods and Protocols, 421\u2013433 (Humana Press, 2012).","DOI":"10.1007\/978-1-61779-430-8_27"},{"key":"77341_CR35","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.tox.2004.01.007","volume":"197","author":"JL Walgren","year":"2004","unstructured":"Walgren, J. L., Jollow, D. J. & McMillan, J. M. Induction of peroxisome proliferation in cultured hepatocytes by a series of halogenated acetates. Toxicology 197, 189\u2013197 (2004).","journal-title":"Toxicology"},{"key":"77341_CR36","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1093\/toxsci\/kfl135","volume":"95","author":"ML Takacs","year":"2006","unstructured":"Takacs, M. L. & Abbott, B. D. Activation of mouse and human peroxisome proliferator\u2013activated receptors (\u03b1, \u03b2\/\u03b4, \u03b3) by perfluorooctanoic acid and perfluorooctane sulfonate. Toxicol. Sci. 95, 108\u2013117 (2006).","journal-title":"Toxicol. Sci."},{"key":"77341_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2020.101727","volume":"23","author":"S Kamata","year":"2020","unstructured":"Kamata, S. et al. PPAR\u03b1 ligand-binding domain structures with endogenous fatty acids and fibrates. iScience 23, 101727 (2020).","journal-title":"iScience"},{"key":"77341_CR38","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1042\/bj2390781","volume":"239","author":"M Bronfman","year":"1986","unstructured":"Bronfman, M., Amigo, L. & Morales, M. N. Activation of hypolipidaemic drugs to acyl-coenzyme A thioesters. Biochem. J. 239, 781\u2013784 (1986).","journal-title":"Biochem. J."},{"key":"77341_CR39","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/0006-2952(91)90010-3","volume":"41","author":"A Aarsland","year":"1991","unstructured":"Aarsland, A. & Berge, R. K. Peroxisome proliferating sulphur- and oxy-substituted fatty acid analogues are activated to acyl coenzyme A thioesters. Biochem. Pharmacol. 41, 53\u201361 (1991).","journal-title":"Biochem. Pharmacol."},{"key":"77341_CR40","doi-asserted-by":"publisher","first-page":"7469","DOI":"10.1021\/ac301572t","volume":"84","author":"GC McAlister","year":"2012","unstructured":"McAlister, G. C. et al. Increasing the multiplexing capacity of TMTs using reporter ion isotopologues with isobaric masses. Anal. Chem. 84, 7469\u20137478 (2012).","journal-title":"Anal. Chem."},{"key":"77341_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17921-y","volume":"11","author":"F Yu","year":"2020","unstructured":"Yu, F. et al. Identification of modified peptides using localization-aware open search. Nat. Commun. 11, 4065 (2020).","journal-title":"Nat. Commun."},{"key":"77341_CR42","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1038\/s41587-020-0549-5","volume":"38","author":"PB Chen","year":"2020","unstructured":"Chen, P. B. et al. Directed remodeling of the mouse gut microbiome inhibits the development of atherosclerosis. Nat. Biotechnol. 38, 1288\u20131297 (2020).","journal-title":"Nat. Biotechnol."},{"key":"77341_CR43","doi-asserted-by":"publisher","first-page":"3183","DOI":"10.1021\/acs.jmedchem.5b01963","volume":"59","author":"P Lassalas","year":"2016","unstructured":"Lassalas, P. et al. Structure property relationships of carboxylic acid isosteres. J. Med. Chem. 59, 3183\u20133203 (2016).","journal-title":"J. Med. Chem."},{"key":"77341_CR44","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1161\/01.ATV.0000227472.70734.ad","volume":"26","author":"CY Han","year":"2006","unstructured":"Han, C. Y. et al. Reciprocal and coordinate regulation of serum amyloid A versus apolipoprotein A-I and paraoxonase-1 by inflammation in murine hepatocytes. Arterioscler. Thromb. Vasc. Biol. 26, 1806\u20131813 (2006).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"77341_CR45","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1161\/ATVBAHA.117.309524","volume":"38","author":"P Robinet","year":"2018","unstructured":"Robinet, P. et al. Consideration of sex differences in design and reporting of experimental arterial pathology studies\u2014statement from ATVB council. Arterioscler. Thromb. Vasc. Biol. 38, 292\u2013303 (2018).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"77341_CR46","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1172\/JCI10370","volume":"106","author":"AC Li","year":"2000","unstructured":"Li, A. C. et al. Peroxisome proliferator\u2013activated receptor \u03b3 ligands inhibit development of atherosclerosis in LDL receptor\u2013deficient mice. J. Clin. Invest. 106, 523\u2013531 (2000).","journal-title":"J. Clin. Invest."},{"key":"77341_CR47","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1038\/31701","volume":"393","author":"B Staels","year":"1998","unstructured":"Staels, B. et al. Activation of human aortic smooth-muscle cells is inhibited by PPAR\u03b1 but not by ppar\u03b3 activators. Nature 393, 790\u2013793 (1998).","journal-title":"Nature"},{"key":"77341_CR48","unstructured":"Bulgheroni, A., Legora, M., Ceriani, D. & Mailland, F. Use of Trifluoroacetic Acid and Salts Thereof to Treat Hypercholesterolemia. Patent # EP2796135 (Polichem S.A., 2014)."},{"key":"77341_CR49","doi-asserted-by":"publisher","first-page":"761","DOI":"10.3109\/00498259309166782","volume":"23","author":"H Permadi","year":"1993","unstructured":"Permadi, H., Lundgren, B., Andersson, K., Sundberg, C. & Depierre, J. W. Effects of perfluoro fatty acids on peroxisome proliferation and mitochondrial size in mouse liver: dose and time factors and effect of chain length. Xenobiotica 23, 761\u2013770 (1993).","journal-title":"Xenobiotica"},{"key":"77341_CR50","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1002\/hep.1840090411","volume":"9","author":"WW Just","year":"1989","unstructured":"Just, W. W. et al. Biochemical effects and zonal heterogeneity of peroxisome proliferation induced by perfluorocarboxylic acids in rat liver. Hepatology 9, 570\u2013581 (1989).","journal-title":"Hepatology"},{"key":"77341_CR51","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1093\/toxsci\/kfp093","volume":"111","author":"JA Bjork","year":"2009","unstructured":"Bjork, J. A. & Wallace, K. B. Structure-activity relationships and human relevance for perfluoroalkyl acid\u2013induced transcriptional activation of peroxisome proliferation in liver cell cultures. Toxicol. Sci. 111, 89\u201399 (2009).","journal-title":"Toxicol. Sci."},{"key":"77341_CR52","unstructured":"\u201cSummary of toxicological and metabolism studies for flurtamone. https:\/\/www.bayer.com\/sites\/default\/files\/m-482307-01-5.pdf\u201d (Bayer CropScience, 2014)."},{"key":"77341_CR53","doi-asserted-by":"publisher","first-page":"2378","DOI":"10.1021\/bi00432a006","volume":"28","author":"RE London","year":"1989","unstructured":"London, R. E. & Gabel, S. A. Determination of membrane potential and cell volume by 19F NMR using trifluoroacetate and trifluoroacetamide probes. Biochemistry 28, 2378\u20132382 (1989).","journal-title":"Biochemistry"},{"key":"77341_CR54","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/0005-2736(93)90118-J","volume":"1150","author":"AS Xu","year":"1993","unstructured":"Xu, A. S. & Kuchel, P. W. Characterisation of erythrocyte transmembrane exchange of trifluoroacetate using 19F-NMR: Evidence for transport via the monocarboxylate transporter. Biochim. Biophys. Acta 1150, 35\u201344 (1993).","journal-title":"Biochim. Biophys. Acta"},{"key":"77341_CR55","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s11883-013-0325-9","volume":"15","author":"JT Chai","year":"2013","unstructured":"Chai, J. T., Digby, J. E. & Choudhury, R. P. GPR109A and vascular inflammation. Curr. Atheroscler. Rep. 15, 325 (2013).","journal-title":"Curr. Atheroscler. Rep."},{"key":"77341_CR56","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1111\/j.1463-1326.2011.01400.x","volume":"13","author":"D Wanders","year":"2011","unstructured":"Wanders, D. & Judd, R. L. Future of GPR109A agonists in the treatment of dyslipidaemia. Diabet. Obes. Metab. 13, 685\u2013691 (2011).","journal-title":"Diabet. Obes. Metab."},{"key":"77341_CR57","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1021\/ml3000676","volume":"3","author":"CA Dvorak","year":"2012","unstructured":"Dvorak, C. A. et al. Identification of hydroxybenzoic acids as selective lactate receptor (GPR81) agonists with antilipolytic effects. ACS Med. Chem. Lett. 3, 637\u2013639 (2012).","journal-title":"ACS Med. Chem. Lett."},{"key":"77341_CR58","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.4049\/jimmunol.1700604","volume":"200","author":"P Ranganathan","year":"2018","unstructured":"Ranganathan, P. et al. GPR81, a cell-surface receptor for lactate, regulates intestinal homeostasis and protects mice from experimental colitis. J. Immunol. 200, 1781 (2018).","journal-title":"J. Immunol."},{"key":"77341_CR59","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/0006-291X(79)91822-9","volume":"87","author":"MR Ball","year":"1979","unstructured":"Ball, M. R., Gumaa, K. A. & McLean, P. Effect of clofibrate on the CoA thioester profile in rat liver. Biochem. Biophys. Res. Commun. 87, 489\u2013496 (1979).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"77341_CR60","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1213\/00000539-199701000-00031","volume":"84","author":"D Njoku","year":"1997","unstructured":"Njoku, D. et al. Biotransformation of halothane, enflurane, isoflurane, and desflurane to trifluoroacetylated liver proteins: association between protein acylation and hepatic injury. Anesth. Analg. 84, 173\u2013178 (1997).","journal-title":"Anesth. Analg."},{"key":"77341_CR61","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1080\/004982599238588","volume":"29","author":"L Constantino","year":"1999","unstructured":"Constantino, L. & Iley, J. I. M. Microsomal metabolism of n,n-diethyl-m-toluamide (DEET, DET): The extended network of metabolites. Xenobiotica 29, 409\u2013416 (1999).","journal-title":"Xenobiotica"},{"key":"77341_CR62","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1002\/cpt.2683","volume":"112","author":"RSP Singh","year":"2022","unstructured":"Singh, R. S. P. et al. Metabolism and excretion of nirmatrelvir in humans using quantitative fluorine nuclear magnetic resonance spectroscopy: a novel approach for accelerating drug development. Clin. Pharmacol. Ther. 112, 1201\u20131206 (2022).","journal-title":"Clin. Pharmacol. Ther."},{"key":"77341_CR63","doi-asserted-by":"publisher","first-page":"213","DOI":"10.4093\/dmj.2020.0001","volume":"44","author":"NH Kim","year":"2020","unstructured":"Kim, N. H. & Kim, S. G. Fibrates revisited: potential role in cardiovascular risk reduction. Diab Metab. J. 44, 213\u2013221 (2020).","journal-title":"Diab Metab. J."},{"key":"77341_CR64","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.3390\/ijms19082189","volume":"19","author":"F Hong","year":"2018","unstructured":"Hong, F., Xu, P. & Zhai, Y. The opportunities and challenges of peroxisome proliferator-activated receptors ligands in clinical drug discovery and development. Int. J. Mol. Sci. 19, 2189 (2018).","journal-title":"Int. J. Mol. Sci."},{"key":"77341_CR65","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1021\/acs.estlett.2c00164","volume":"9","author":"F Freeling","year":"2022","unstructured":"Freeling, F. et al. Levels and temporal trends of trifluoroacetate (TFA) in archived plants: evidence for increasing emissions of gaseous TFA precursors over the last decades. Environ. Sci. Technol. Lett. 9, 400\u2013405 (2022).","journal-title":"Environ. Sci. Technol. Lett."},{"key":"77341_CR66","doi-asserted-by":"publisher","first-page":"11093","DOI":"10.1021\/acs.est.9b02211","volume":"53","author":"MK Bj\u00f6rnsdotter","year":"2019","unstructured":"Bj\u00f6rnsdotter, M. K., Yeung, L. W. Y., K\u00e4rrman, A. & Jogsten, I. E. Ultra-short-chain perfluoroalkyl acids including trifluoromethane sulfonic acid in water connected to known and suspected point sources in sweden. Environ. Sci. Technol. 53, 11093\u201311101 (2019).","journal-title":"Environ. Sci. Technol."},{"key":"77341_CR67","doi-asserted-by":"publisher","first-page":"31521","DOI":"10.1074\/jbc.M103306200","volume":"276","author":"JW Lawrence","year":"2001","unstructured":"Lawrence, J. W. et al. Differential gene regulation in human versus rodent hepatocytes by peroxisome proliferator-activated receptor (PPAR) \u03b1: PPAR\u03b1 fails to induce peroxisome proliferation-associated genes in human cells independently of the level of receptor expression. J. Biol. Chem. 276, 31521\u201331527 (2001).","journal-title":"J. Biol. Chem."},{"key":"77341_CR68","doi-asserted-by":"publisher","first-page":"3149","DOI":"10.1172\/JCI25482","volume":"115","author":"AE Mullick","year":"2005","unstructured":"Mullick, A. E., Tobias, P. S. & Curtiss, L. K. Modulation of atherosclerosis in mice by Toll-like receptor 2. J. Clin. Invest. 115, 3149\u20133156 (2005).","journal-title":"J. Clin. Invest."},{"key":"77341_CR69","doi-asserted-by":"crossref","unstructured":"Patel, H. et al. The nf-core framework for community-curated bioinformatics pipelines. Nat. Biotechnol. 38, 276\u2013278 (2020).","DOI":"10.1038\/s41587-020-0439-x"},{"key":"77341_CR70","doi-asserted-by":"crossref","unstructured":"Ulgen, E., Ozisik, O., Sezerman, O. U. PathfindR: an R package for comprehensive identification of enriched pathways in omics data through active subnetworks. Front. Gen. 10, 858 (2019).","DOI":"10.3389\/fgene.2019.00858"},{"key":"77341_CR71","doi-asserted-by":"publisher","first-page":"W242","DOI":"10.1093\/nar\/gky354","volume":"46","author":"J-P Concordet","year":"2018","unstructured":"Concordet, J.-P. & Haeussler, M. CRISPOR: intuitive guide selection for CRISPR\/Cas9 genome editing experiments and screens. Nucleic Acids Res. 46, W242\u2013W245 (2018).","journal-title":"Nucleic Acids Res."},{"key":"77341_CR72","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1038\/nprot.2013.143","volume":"8","author":"FA Ran","year":"2013","unstructured":"Ran, F. A. et al. Genome engineering using the CRISPR-Cas9 system. Nat. Protoc. 8, 2281\u20132308 (2013).","journal-title":"Nat. Protoc."},{"key":"77341_CR73","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1007\/s00216-016-0048-1","volume":"409","author":"K Wegner","year":"2017","unstructured":"Wegner, K. et al. Rapid analysis of bile acids in different biological matrices using LC-ESI-MS\/MS for the investigation of bile acid transformation by mammalian gut bacteria. Anal. Bioanal. Chem. 409, 1231\u20131245 (2017).","journal-title":"Anal. Bioanal. Chem."},{"key":"77341_CR74","doi-asserted-by":"publisher","first-page":"7839","DOI":"10.1039\/D1SC01360B","volume":"12","author":"LP Conway","year":"2021","unstructured":"Conway, L. P. et al. Evaluation of fully-functionalized diazirine tags for chemical proteomic applications. Chem. Sci. 12, 7839\u20137847 (2021).","journal-title":"Chem. Sci."},{"key":"77341_CR75","doi-asserted-by":"publisher","first-page":"D543","DOI":"10.1093\/nar\/gkab1038","volume":"50","author":"Y Perez-Riverol","year":"2021","unstructured":"Perez-Riverol, Y. et al. The PRIDE database resources in 2022: A hub for mass spectrometry-based proteomics evidences. Nucleic Acids Res. 50, D543\u2013D552 (2021).","journal-title":"Nucleic Acids Res."},{"key":"77341_CR76","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/nmeth.4256","volume":"14","author":"AT Kong","year":"2017","unstructured":"Kong, A. T., Leprevost, F. V., Avtonomov, D. M., Mellacheruvu, D. & Nesvizhskii, A. I. MSFragger: ultrafast and comprehensive peptide identification in mass spectrometry\u2013based proteomics. Nat. Meth. 14, 513\u2013520 (2017).","journal-title":"Nat. Meth."},{"key":"77341_CR77","doi-asserted-by":"publisher","first-page":"2511","DOI":"10.1021\/acs.jproteome.0c00119","volume":"19","author":"H-Y Chang","year":"2020","unstructured":"Chang, H.-Y. et al. Crystal-C: a computational tool for refinement of open search results. J. Proteome Res. 19, 2511\u20132515 (2020).","journal-title":"J. Proteome Res."},{"key":"77341_CR78","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1021\/acs.jproteome.0c00544","volume":"20","author":"GC Teo","year":"2021","unstructured":"Teo, G. C., Polasky, D. A., Yu, F. & Nesvizhskii, A. I. Fast deisotoping algorithm and its implementation in the MSFragger search engine. J. Proteome Res. 20, 498\u2013505 (2021).","journal-title":"J. Proteome Res."},{"key":"77341_CR79","doi-asserted-by":"publisher","first-page":"100018","DOI":"10.1074\/mcp.TIR120.002216","volume":"20","author":"DJ Geiszler","year":"2021","unstructured":"Geiszler, D. J. et al. PTM-Shepherd: analysis and summarization of post-translational and chemical modifications from open search results. Mol. Cell. Proteom. 20, 100018 (2021).","journal-title":"Mol. Cell. Proteom."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77341-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77341-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77341-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T11:02:54Z","timestamp":1791198174000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77341-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,2]]},"references-count":79,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["77341"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-77341-2","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,2]]},"assertion":[{"value":"8 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Scripps Research has filed a provisional patent covering novel therapeutic uses of TFA and structural analogs (application no. 63\/763,336), with M.R.G., L.J.L., W.T., A.S.B., J.A.R.G., and J.J.Z. listed as inventors. The remaining authors declare that they have no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"10459"}}